Vernalis PLC Announces CTI Becomes Worldwide Licensee for Tosedostat

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 10/27/14 -- Vernalis PLC (LSE: VER); (PINKSHEETS: VNLPY)27 October 2014…

Continue Reading

Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 10/10/14 -- Vernalis plc (LSE: VER) today announces it has…

Continue Reading

Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 10/09/14 -- Vernalis plc (LSE: VER) (PINKSHEETS: VNLPY)Vernalis plc today…

Continue Reading

Vernalis Announces Successful Study With CCP-01

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 11/25/13 --Contacts: RNS Customer Services 0044-207797-4400

Vernalis plc enters into research collaboration

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 10/01/13 --Contacts: RNS Customer Services 0044-207797-4400

Vernalis plc: Interim results for six months ended 30 June 2013

WINNERSH, UK -- (Marketwired) -- 07/29/13 --Contacts: RNS Customer Services 0044-207797-4400

Vernalis Initiates Phase Ib/II POC Study of V81444

WINNERSH, UK -- (Marketwired) -- 07/12/13 --Contacts: RNS Customer Services 0044-207797-4400

Vernalis PLC: Notice of Results for 6 months ended 30 June 2013

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 07/11/13 -- Vernalis PLC (LSE: VER)Contacts: RNS Customer Services 0044-207797-4400

Continue Reading

Vernalis plc: Announcement of Results for year ended 31/12/12

WINNERSH, UK -- (Marketwired) -- 04/10/13 --Contacts: RNS Customer Services 0044-207797-4400